Share this article Share this article SINGAPORE and COPENHAGEN, Denmark, April 21, 2021 /PRNewswire/ -- Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, an Indonesia-based healthtech platform, which was led by PT Astra Digital Internasional, a subsidiary of PT Astra International Tbk (Astra) and joined by existing and new investors including Temasek, Telkomsel's TMI, Acrew Diversify Capital Fund, Bangkok Bank, UOB Venture Management, Singtel Innov8, BliBli, Allianz X, and Openspace Ventures. This is the first investment by the Novo Holdings Asian life sciences team in Singapore following set up in 2020. Founded in 2016, Halodoc is a digital healthcare platform that includes a mobile app and website allowing customers across Indonesia to have live consultations with more than 20,000 licensed doctors in the country at any time regardless of where they are. In 2020, the company launched an appointment service that connects over 2000 providers (hospitals, clinics, laboratories) to patients in over 180 cities across the country. Halodoc's proven track record, led the Ministry of Health appointing it to help roll out Indonesia's national vaccination program. Halodoc vaccinated over 50,000 citizens across two islands in the first 23 days of the vaccination program, making it one of the country's leading vaccination facilitators.